SCHEMBL65868

SCHEMBL65868

CC(C)CC(NC(=O)CN)C(=O)O

nearest known ligand 0.62

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.62
MEN1 O00255 1/20 0.58
LMNA P02545 1/20 0.58
KMT2A Q03164 1/20 0.58
MAPT P10636 1/20 0.55
LAP3 P28838 3/20 0.53
FOLH1 Q04609 5/20 0.51
GRN P28799 2/20 0.50
SORT1 Q99523 2/20 0.50
MME P08473 1/20 0.50
CTSC P53634 1/20 0.47
NAALAD2 Q9Y3Q0 2/20 0.47
PLA2G2A P14555 2/20 0.46
PLA2G5 P39877 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29148902 1.00 ALDH1A1 (0.62) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL65869 1.00 ALDH1A1 (0.62) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL9576054 0.93 ALDH1A1 (0.55) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL29645227 0.88 MME (0.53) ALDH1A1MEN1LMNAKMT2AMAPT
Leucine SCHEMBL28698190 0.88 SLC7A5 (0.56) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL29645226 0.88 MME (0.53) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL1674751 0.88 ALDH1A1 (0.53) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL1674750 0.88 ALDH1A1 (0.53) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL18613505 0.88 ALDH1A1 (0.53) ALDH1A1MEN1LMNAKMT2AMAPT
SCHEMBL8017457 0.88 ALDH1A1 (0.53) ALDH1A1MEN1LMNAKMT2AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1426 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4709912-A1 PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS BioAtla, Inc. (US) 2026-03-18 EP claimed
EP-4607278-A1 CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT Ycchem Co., Ltd. (KR) 2025-08-27 EP claimed
US-20250199405-A1 CHEMICALLY-AMPLIFIED POSITIVE PHOTORESIST COMPOSITION FOR PATTERN PROFILE IMPROVEMENT AND ETCH RESISTANCE ENHANCEMENT YCCHEM CO., LTD. (KR) 2025-06-19 US claimed
CN-119555942-A Fecal metabolite combination for auxiliary diagnosis of subclinical mastitis of dairy cows and application thereof 武汉市农业科学院 2025-03-04 CN claimed
WO-2024232976-A1 PROTEIN THERAPEUTICS FOR TREATMENT OF SENESCENT CELLS BIOATLA, INC. (US) 2024-11-14 WO claimed
CN-118406439-B Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing 万华化学集团电子材料有限公司 2024-10-18 CN claimed
EP-4424365-A2 PET FOOD COMPOSITIONS Hill's Pet Nutrition, Inc. (US) 2024-09-04 EP claimed
EP-4017281-B1 PET FOOD COMPOSITIONS HILLS PET NUTRITION INC (US) 2024-08-28 EP claimed
US-12050228-B2 Automated sample quality assessment METABOLON, INC. (US) 2024-07-30 US claimed
CN-118406439-A Chemical mechanical polishing composition and application thereof in tungsten chemical mechanical polishing 万华化学集团电子材料有限公司 2024-07-30 CN claimed
EP-1282680-A1 COMPOSITIONS COMPRISING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 2003-02-12 EP claimed
US-6503413-B2 Polyalkylene polysiloxane, buffering agent, aqueous carrier THE PROCTER & GAMBLE COMPANY 2003-01-07 US claimed
EP-1255806-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2002-11-13 EP claimed
US-6429220-B1 COMPRISES AN ISOTHIAZOLONE COMPOUND AND AN AMINOCARBOXYLIC ACID KURITA WATER INDUSTRIES LTD. (JP) 2002-08-06 US claimed
US-20020011584-A1 Stable, aqueous compositions for treating surfaces, especially fabrics THE PROCTOR & GAMBLE COMPANY 2002-01-31 US claimed
US-20020010154-A1 Compositions comprising cyclodextrin THE PROCTER & GAMBLE COMPANY 2002-01-24 US claimed
WO-2001088076-A1 COMPOSITIONS COMPRISING CYCLODEXTRIN THE PROCTER & GAMBLE COMPANY (US) 2001-11-22 WO claimed
WO-2001060961-A1 STABLE, AQUEOUS COMPOSITIONS FOR TREATING SURFACES, ESPECIALLY FABRICS THE PROCTER & GAMBLE COMPANY (US) 2001-08-23 WO claimed
US-4427762-A DEVELOPMENT WITH ALKALINE DEVELOPER MIXTURE KONISHIROKU PHOTO INDUSTRY CO., LTD. (JP) 1984-01-24 US claimed
EP-0082015-A1 Method of forming an image with a photographic cuprous halide material KONICA CORPORATION (JP) 1983-06-22 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020010154-A1 Compositions comprising cyclodextrin FFAR4, FRG1, FGB ALDH1A1 3053/4885MEN1 4077/4885LMNA 4083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.